Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Khandaker et al., 2015
Their invaluable expertise plays a pivotal role in steering our product innovation and growing our company
Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with graves disease
HX: Investigation, Writing review and editing, Resources
Todays fast-paced lifestyle, stress, and processed foods often leave our diets short on Zinc-rich foods like shellfish, oysters, red meat, and lentils
Pemvidutide in alcohol-associated liver disease (ALD) Recent Highlights: In May 2026, the company announced that Pemvidutide demonstrated significant metabolic improvements in patients with MASH in new 48week IMPACT Phase 2b data
US$ 23.70
US$ 26.56
US$ 23.19
US$ 21.01
